BMS-986460 / BMS - LARVOL DELTA

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - P1 | N=140 | Recruiting | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Recruiting

Enrollment open • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor

CA125-1018: A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants (clinicaltrials.gov) - P1 | N=85 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed | N=56 ➔ 85

Enrollment change • Trial completion

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - P1 | N=140 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | N=90 ➔ 140 | Trial completion date: Jan 2029 ➔ Jul 2031 | Trial primary completion date: Jan 2027 ➔ Aug 2029

Enrollment change • Trial completion date • Trial primary completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - P1 | N=90 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting

Enrollment closed • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor

CA125-1018: A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants (clinicaltrials.gov) - P1 | N=56 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting

Enrollment open

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants (clinicaltrials.gov) - P1 | N=56 | Not yet recruiting | Sponsor: Bristol-Myers Squibb

New P1 trial

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - P1 | N=90 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov) - P1 | N=90 | Not yet recruiting | Sponsor: Bristol-Myers Squibb

Metastases • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor